← Open Payments lookup

AMBER VASOLD: Open Payments

NPI 1013389683 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,289 in 65 payments from 13 companies in 2025. Trend: 2023 $2,260 · 2024 $1,822 · 2025 $1,289

Food & beverage: $1,289
CompanyPaymentsAmount
Novo Nordisk Inc10$265
Amgen Inc.18$244
AstraZeneca Pharmaceuticals LP8$164
ABBVIE INC.8$138
GlaxoSmithKline, LLC.5$95
Lilly USA, LLC4$91
PFIZER INC.4$80
INTUITIVE SURGICAL, INC.1$77
Boehringer Ingelheim Pharmaceuticals, Inc.2$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37

Products named: OTEZLA, FARXIGA, EVENITY, Wegovy, TRELEGY ELLIPTA, MOUNJARO, Ozempic, Rybelsus.

Industry payments across MD — which companies pay providers there.